Application of Validated HPLC Method for Degradation Study of Vildagliptin and Metformin HCl

Imran A Sheikh, Manoj S. Charde, Rita D. Chakole

Abstract


A novel and simple reverse phase liquid chromatographic method has been established for the determination of Vildagliptin and Metformin HCl and studies its degradation pattern in pharmaceutical dosage forms. Vildagliptin and Metformin HCl is used to control Type 2 Diabetes. The proposed work was performed on Younglin (S.K) isocratic System UV Detector C18 column (150 mm × 4.6 mm). A mixture of Potassium Phosphate, mobile phase in this method with flow rate 0.7 ml/min (UV detection at 203 nm) and the method was validated as per ICH guidelines. Forced degradation studies were performed by exposing the drug Vildagliptin and Metformin HCl to acidic, alkaline, oxidation and thermal stress degradations. The proposed RP-HPLC method was found to be robust and specific and this method is suitable for the assay of pharmaceutical dosage forms as well as kinetic studies.

Keywords


Vildagliptin, Metformin HCl, RP-HPLC, validation, stability-indicating

Full Text:

PDF

References


. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.

. Elfrides ES, Schapoval and Martin S, Stability-Indicating RP-LC Method for the Determination of Vildagliptin and Mass Spectrometry Detection for a Main Degradation Product, Journal of Chromatographic Sgcience, (2011), Volume 50 Issue.

. Shaw RJ, Lamia KA, Vasquez D, et al: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310: 1642–1646.

. El-Mir MY, Nogueira V, Fontaine E, et al: Dimethyl biguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J BiolChem 2000; 275: 223–228.

. Zhong GP, Bi HC, Zhou S, Chen X, Huang M. Simultaneous determination of Metformin and gliclazide in human plasma by liquid chromatography-tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers. Journal of Mass Spectrometry.2005; 40(11): 1462–71.8.

. Marlice ASM, Alcenir SS, Olivia WP, Pedro TWB, Douglas PP, Milton FF. Simple and rapid method determination for Metformin in human plasma using high performance liquid chromatography tandem mass spectrometry: Application to pharmacokinetic studies. Journal of ChromatographyB.2007; 852(1): 308–16.9.

. Heinig K, Bucheli F. Fast liquid chromatographic-tandem mass spectrometric (LC–MS–MS)determination of Metformin in plasma samples. Journal of Pharmaceutical and Biomedical Analysis. 2004; 34(5): 1005–11.10.

. Porta V, Schramm SG, Kano EK, Koono EE, Armando YP, Fukuda K. HPLC-UV determination of Metformin in human plasma for application in pharmacokinetics and bioequivalence studies. Journal of Pharmaceutical and Biomedical Analysis. 2008; 46(1): 143–7.11.

. RaniahQ, Gabr RS, Padwal D, Brocks R.Determination of Metformin in Human Plasma and Urine by High-Performance Liquid Chromatography Using Small Sample Volume and Conventional OctadecylSilane Column.

. Journal of Pharmacy and Pharmaceutical Sciences2010; 13(4): 486–94.

. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Rapid determination of Metformin in human plasma using ion-pair HPLC. Journal of Pharmaceutical and Biomedical Analysis. 2003; 31(1): 197–200.

. AbuRuz S, Millership J, McElnay J. Determination of Metformin in plasma using a new ion pair solid phase extraction technique and ion pair liquid chromatography

. Journal of Chromatography. B Analytical Technology and Biomedical Life Sciences. 2003; 798(2): 203–9.




DOI: http://dx.doi.org/10.7439/ijpc.v7i8.4376

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 International Journal of Pharmaceutical Chemistry

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.